CRISM Therapeutics Corporation
CRTX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£607 | -£1,923 | -£2,115 | -£1,302 |
| Dep. & Amort. | £16 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£55 | £0 | £0 | £0 |
| Other Non-Cash | -£287 | -£847 | -£1,400 | -£531 |
| Operating Cash Flow | -£933 | -£2,770 | -£2,726 | -£1,095 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£28 | £0 | -£265 | -£310 |
| Net Acquisitions | £2,356 | £0 | £114 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £4,462 |
| Other Inv. Act. | £0 | £34,931 | -£360 | £1,885 |
| Investing Cash Flow | £2,328 | £34,931 | -£511 | £6,038 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £102 | £0 | £345 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | -£47 | -£31,447 | £0 | £0 |
| Other Fin. Act. | -£122 | £0 | £623 | £0 |
| Financing Cash Flow | -£67 | -£31,447 | £968 | £0 |
| Forex Effect | -£47 | £46 | £0 | -£313 |
| Net Chg. in Cash | £1,281 | £760 | -£3,058 | £3,892 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1 | £3,624 | £4,933 | £2,041 |
| End Cash | £1,282 | £4,384 | £2,896 | £4,933 |
| Free Cash Flow | -£961 | -£2,770 | -£2,992 | -£1,405 |